Before and After Allergy Shots: The Realistic 4-Stage Timeline
Meaningful symptom relief from subcutaneous allergy shots arrives at 6-12 months — not weeks — because SCIT works by reprogramming T-regulatory cells, not by suppressing histamine. Maximum benefit accumulates in years 2-3. Durham SR et al, NEJM 1999;341:468-475 documented 7-12+ years of durable remission after a completed 3-year grass course, but Tkacz 2021 (n=103,207) found only 43.9% of patients ever reach maintenance.
7 peer-reviewed sources
Expect partial, unreliable relief in months 1-6, noticeable improvement at months 6-12, maximum benefit by years 2-3, and 7-12+ years of durable remission after completing a full 3-5 year course.
The essentials
The honest answer to 'what should I see before and after allergy shots' is that the timeline is measured in months and years, not weeks. Patients who expect a dramatic transformation after 6 weeks of injections are almost always disappointed — not because the treatment fails, but because they misunderstand how subcutaneous immunotherapy works immunologically.
SCIT induces tolerance by driving the immune system toward T-regulatory cell dominance and IgG4 blocking antibody production. These are slow immunological processes — they are not the same as taking an antihistamine that blocks histamine within an hour. Cox 2011 PP3 explicitly states that patients should not expect significant clinical benefit during the build-up phase.
Before committing to this 3-5 year course, knowing exactly which allergens are driving your symptoms matters enormously. Curex offers at-home IgE testing covering 40+ allergens with results in about a week, giving your allergist the sensitization map needed to design your extract correctly and set accurate before-and-after expectations for your specific sensitization pattern.
Here is the honest four-window timeline based on published evidence:
Months 1-6 (Build-up): One injection per week, with escalating doses. Symptom relief is partial and unreliable. Patients on grass SCIT starting in October may not feel any benefit until the spring grass season of year 2. Local reactions are actually at their highest frequency during this phase — the Calabria/Tankersley LOCAL study found 78.3% of patients experience at least one local reaction across a full course, and early build-up concentrations are rising weekly.
Months 6-12 (Early maintenance): Injections space to every 2-4 weeks. Most patients report the first noticeable improvement in this window — the inflection point where some find they have forgotten to take their daily antihistamine. Cochrane meta-analysis (Calderón 2007, 51 RCTs, 2,871 patients) documented an average symptom reduction SMD of -0.73 and medication reduction SMD of -0.57.
Years 2-3 (Maximum benefit): The largest and most consistent symptom and medication reductions typically accumulate here. This is what the before-and-after photographs that circulate online are actually showing — year 3 patients, not month 3 patients.
Years 4-5+ (Maintenance and discontinuation): Durham SR et al, NEJM 1999;341:468-475 randomized patients who completed 3-4 years of grass SCIT to stop or continue, and the discontinuation group maintained remission comparable to continued treatment. 7-12+ years of durable remission is documented. The Jacobsen PAT study (Allergy 2007) showed 3-year SCIT in children reduced new asthma development 10 years later with an odds ratio of 4.6.
The unspoken half of every before-and-after story: Tkacz JP et al, Curr Med Res Opin 2021 (n=103,207 AIT patients) found 23.9% never returned after initiating treatment, and only 43.9% reached maintenance. Most 'before' patients never reach 'after' because they quit during build-up.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Treatment timeline — phase by phase
The SCIT timeline is the before-and-after story. Three phases define the clinical course, with the discontinuation decision anchored on Durham 1999 NEJM evidence.
Weekly injections at escalating concentrations to reach the maintenance dose. Cox 2011 PP3 advises patients not to expect significant clinical benefit during this phase. Local reactions are at their peak frequency. Partial and unreliable relief only.
Most patients notice first clear improvement at months 6-12. Maximum benefit accumulates by years 2-3. Continued injections sustain immune tolerance. Only 43.9% of initiated patients reach this phase per Tkacz 2021 (n=103,207).
Durham SR et al, NEJM 1999;341:468-475 documented 7-12+ years of durable remission after a completed 3-year course. Jacobsen PAT (Allergy 2007) showed 10-year asthma prevention in children. 25-40% of patients relapse over 5 years; re-initiation is possible per Cox 2011 PP3.
Efficacy by allergen — what the data shows
Efficacy data from landmark trials frames what 'after' realistically looks like. The Cochrane SMDs represent the population average — individual outcomes vary by allergen, adherence, and sensitization profile.
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youTreatment options side by side
Patients weighing the before-and-after timeline of SCIT against alternatives need an honest comparison of how long each approach takes to deliver benefit and whether that benefit persists after stopping.
| Treatment | Efficacy | Duration | Cost (5yr) | Convenience | Safety |
|---|---|---|---|---|---|
Allergy Shots (SCIT) | |||||
Sublingual Drops (SLIT) | |||||
Antihistamines (daily) |
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
For patients unwilling to commit to 24-28 weekly clinic visits during build-up, Curex delivers the same allergy-shot immunotherapy at home for $129/month — one weekly injection you give yourself, no facility fees, the identical 3-5 year immunologic reprogramming. A board-certified allergist designs the plan, the serum is sterile-compounded to USP <797>, a prescribed epinephrine auto-injector is confirmed on hand, and your first dose and every dose change are supervised live over Zoom.
See if at-home shots are right for youSide effects — what to watch for
During the before-and-after timeline, patients will encounter a predictable side-effect arc. Local reactions are most frequent in the build-up phase because doses are escalating weekly. Understanding the reaction landscape helps frame expectations and prevents early dropout driven by preventable anxiety.
Frequently asked questions
When do allergy shots start working?
Meaningful symptom relief from allergy shots typically begins at months 6-12, during early maintenance. The first 6 months (build-up phase) are an investment — injections escalate weekly to reach an effective maintenance dose, and Cox 2011 PP3 explicitly states patients should not expect significant clinical benefit during this phase. Patients sensitized to seasonal pollens may not notice improvement until the first allergy season after completing build-up, which can be 12-18 months into treatment. Maximum benefit accumulates in years 2-3 of maintenance per multi-trial evidence and Cochrane meta-analysis (Calderón 2007, SMD -0.73 for symptoms).
How long does the benefit from allergy shots last after stopping?
Durham SR et al (NEJM 1999;341:468-475) demonstrated that patients who completed 3-4 years of grass SCIT maintained clinical remission for at least 3 further years after stopping — comparable to those who continued treatment. Longer-term observational data describe continued benefit 7-12+ years post-course in responders. However, relapse does occur: the rate varies from roughly 0% to 55% depending on allergen, with dust mite having higher relapse rates than grass pollen. Benefit depends on completing the full course; patients who stop during build-up have not established the durable immunological changes documented in the Durham 1999 trial.
What percentage of allergy shot patients actually finish treatment?
In a large US commercial-claims study (Tkacz JP et al, Curr Med Res Opin 2021, n=103,207 AIT patients), only 43.9% of patients reached the maintenance phase — meaning more than half never achieved the dose level where maximum efficacy is established. An additional 23.9% never returned for even a single injection after initiating the prescription. These dropout rates are the primary reason real-world outcomes lag behind clinical trial data. Common dropout drivers include local reaction burden during build-up, the time commitment of weekly clinic visits, and 30-minute observation requirements that affect work schedules.
Can allergy shots prevent asthma?
Yes, in children — this is one of the most compelling long-term before-and-after findings from SCIT. The PAT (Prevention of Allergy and Asthma in Children) study (Jacobsen L et al, Allergy 2007) followed children who received a 3-year course of grass and/or birch SCIT. At 10-year follow-up, the odds ratio for remaining asthma-free was 4.6 (95% CI 1.5-13.7) favoring SCIT. The original PAT trial (Möller C et al, JACI 2002) showed fewer new asthma diagnoses at 3-year follow-up. This preventive effect persisted approximately 7 years after treatment ended — establishing that the pediatric 'before' of allergic rhinitis without asthma can remain the 'after' well into adulthood with early SCIT intervention.
Is it normal to have more swelling in the first weeks of allergy shots?
Yes, local reactions are actually more frequent during the build-up phase than during maintenance, because doses are escalating weekly and your immune system is encountering increasing allergen concentrations. The Calabria/Tankersley LOCAL study found 78.3% of patients experience at least one local reaction across a full SCIT course, with a per-injection rate of 16.3%. Large local reactions (swelling ≥25 mm) occur in 0.4% of injections and trigger a dose-adjustment protocol per Cox 2011 PP3. Importantly, local reactions do not predict systemic reactions — having frequent arm swelling in build-up does not mean you are at higher risk of anaphylaxis.
What happens to allergy shots benefits if I stop early?
Stopping before completing the 3-5 year course significantly limits durability. The evidence base for long-term remission — most prominently Durham SR et al, NEJM 1999;341:468-475 — is anchored on completed 3-4 year courses. Patients who stop during build-up have not reached the maintenance-dose level where maximal immune tolerance develops, meaning any symptom improvement is likely to fade within 1-2 allergy seasons. Patients who complete build-up and partial maintenance (1-2 years) may retain some benefit, but the robust 7-12+ year remission data does not apply to incomplete courses. Re-initiating treatment is possible after relapse, typically with an abbreviated build-up per Cox 2011 PP3.
Do allergy shots work for everyone?
No. Allergy shots work best for patients who are correctly sensitized to the allergens in their prescribed extract, who have well-controlled asthma if comorbid, and who complete the full 3-5 year course. Response is strongest for grass, ragweed, cat, and venom — where well-controlled RCTs document clear benefit. Evidence is thinner for most molds and some trees. Multi-allergen vials can dilute each component below effective maintenance concentration, complicating efficacy. Cochrane meta-analysis (Calderón 2007) found an average symptom SMD of -0.73 across 51 RCTs — meaningful but not complete elimination of symptoms for all patients. Monosensitized patients generally respond more predictably than highly polysensitized patients.
When is the 'after' in allergy shots most dramatic?
The most dramatic 'after' moment for most patients is the second or third allergy season during maintenance — typically years 2-3. This is when maximum benefit has accumulated per the multi-trial evidence reviewed in Cox 2011 PP3, and when patients most commonly report they have stopped their daily antihistamine or stopped needing their rescue inhaler during pollen season. The Walker SM et al (JACI 2001;107:87-93) grass SCIT trial documented approximately 49% symptom reduction and 80% medication score reduction at this stage. The Cochrane SMD of -0.73 represents this population-level average for the years-2-3 window, not the first 6 months.
Related Articles
Cat Allergy Shot for Humans | Curex SCIT Guide
This page covers cat allergy shots FOR HUMANS — SCIT with FDA-standardized Fel d 1 extract (10,000 BAU/mL). Not Cytopoint. Not Apoquel. ~72% symptom reduction in RCTs.
Read moreWhere To Get Allergy Shots | Curex Allergy Shot Guide
Get allergy shots at an allergist office or at home with Curex SCIT ($129/mo). HOPD sites can bill $24,400 for what a freestanding clinic charges $1,827.
Read moreRash After Allergy Shot | Curex Allergy Shot Guide
Rash after an allergy shot can be urticaria (grade 1 systemic), local erythema (normal), or contact dermatitis from prep solution. Each has a different protocol.
Read moreSwollen Arm After Allergy Shot | Curex Allergy Shot Guide
Swollen arm after an allergy shot is normal in 78.3% of patients. Measure diameter at 6–8 hours. Under 25mm: ice and antihistamine. Swelling plus spreading hives: call 911.
Read moreHives After Allergy Shot — Reaction Grade Guide | Curex
Generalized hives after an allergy shot is a WAO grade 1 systemic reaction occurring in ~0.1% of visits. Know the protocol — and when to call 911 instead.
Read moreAllergy Shot Side Effects: Per-Injection Timeline | Curex
What happens after each allergy shot? A minute-by-minute timeline from the 30-min wait to 48-hour local reactions, with safety thresholds and real data.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.